2
Cite Share
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro.
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
MAbs. 2021 Jan-Dec;13(1):1919285. doi: 10.1080/19420862.2021.1919285.
PMID: 34074219 Free PMC article.
3
Cite Share
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.
Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
Cell Res. 2021 Jun;31(6):720-722. doi: 10.1038/s41422-021-00496-8. Epub 2021 Apr 23.
PMID: 33893398 Free PMC article. No abstract available.
4
Cite Share
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro.
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
bioRxiv. 2021 Feb 16:2021.02.16.431305. doi: 10.1101/2021.02.16.431305. Preprint.
PMID: 33619479 Free PMC article. Updated.
5
Cite Share
The basis of a more contagious 501Y.V1 variant of SARS-COV-2.
Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Peterson S, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
bioRxiv. 2021 Feb 2:2021.02.02.428884. doi: 10.1101/2021.02.02.428884. Preprint.
PMID: 33564771 Free PMC article. Updated.
2
Cite Share
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro.
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
MAbs. 2021 Jan-Dec;13(1):1919285. doi: 10.1080/19420862.2021.1919285.
PMID: 34074219 Free PMC article.
3
Cite Share
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2.
Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
Cell Res. 2021 Jun;31(6):720-722. doi: 10.1038/s41422-021-00496-8. Epub 2021 Apr 23.
PMID: 33893398 Free PMC article. No abstract available.
4
Cite Share
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro.
Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
bioRxiv. 2021 Feb 16:2021.02.16.431305. doi: 10.1101/2021.02.16.431305. Preprint.
PMID: 33619479 Free PMC article. Updated.
5
Cite Share
The basis of a more contagious 501Y.V1 variant of SARS-COV-2.
Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Peterson S, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G.
bioRxiv. 2021 Feb 2:2021.02.02.428884. doi: 10.1101/2021.02.02.428884. Preprint.
PMID: 33564771 Free PMC article. Updated.